Research infrastructures services to support research addressing cancer
This Horizon Europe program aims to bolster cancer research by providing extensive access to cutting-edge research infrastructure services across Europe and beyond. It seeks to integrate diverse services, including data and modelling, to accelerate the development of personalized cancer prevention and treatment strategies. The initiative fosters interdisciplinary collaboration and aims to translate research findings into practical solutions for patients, contributing to the EU's broader health and digital transformation goals.
Who is Funded
This section details the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives. The program targets research institutions and businesses involved in health and cancer research, supporting entities within the EU, Associated Countries, and specific international partners to advance scientific excellence and societal impact.
What is Funded
This section outlines the types of projects and activities supported, the thematic areas, and eligible costs. The program focuses on integrating research infrastructure services to advance cancer research from discovery to clinical application, covering both direct and indirect costs for access provision.
Type and Scope of Funding
This section provides information on the financial support available, including the type of funding instrument and the maximum funding amounts per project. The program offers grants to support significant research initiatives.
Conditions and Requirements
This section outlines the key conditions and requirements that applicants and beneficiaries must adhere to, covering aspects from application submission to specific operational provisions and collaborations.
Application Procedure
This section provides a guide to the application process, from submission requirements to how proposals are evaluated and selected for funding. Understanding these steps is crucial for successful participation.
Legal Basis
This section identifies the foundational legal and official documents that govern the program, providing transparency and a clear framework for its operation within the broader European research and innovation landscape.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
Between 10,000,000 € and 15,000,000 € per grant.
Allocated Budget:
Total budget of 122,500,000 € for the overall call HORIZON-INFRA-2021-SERV-01. For this specific topic (HORIZON-INFRA-2021-SERV-01-01), the estimated budget for 2021 was 70,000,000 €.
Award Channel:
Framework Programme Call
Region:
European Research Area (encompassing EU Member States and Associated Countries) and, for specific access providers, Australia, Brazil, Canada, China, India, Japan, Mexico, New Zealand, Republic of Korea, Russia, Singapore, and USA.
Sectors:
Healthcare, Research and Development, Pharmaceutical Industry
Beneficiaries:
Research communities, European industry, biotech SMEs, patients
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Product Development, Market Introduction, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Research Executive Agency (REA)
Website: